Andon Health Co., Ltd.

Andon Health Co., Ltd. is a manufacturing company listed on the Shenzhen Stock Exchange since 2010, specializing in the medical device industry. With nearly 30 years of experience, Andon focuses on the development and promotion of innovative diabetes diagnosis and care solutions, particularly the "O+O" model, which integrates online and offline medical services. The company's main products include sphygmomanometers, blood glucose meters, and thermometers, marketed under the well-regarded brands "Andon" and "iHealth." The company operates primarily in the diabetes management sector, leveraging its extensive experience and brand reputation to establish a strong market presence in both China and the United States. Andon has developed a dedicated business team to advance its "AIoT Diabetes Home Healthcare Assistant" project, aiming to enhance chronic disease management through cutting-edge AI technology. Additionally, the company has a robust asset management strategy, focusing on long-term asset preservation and appreciation while actively engaging in investment activities to support its core business strategies and mitigate future risks.

1. Global Business Coverage advantage 2. Brand&channel advantage 3. Advantage on extensive accumulation of private-domain data and its application within vertical models 4. Authentication access advantage 5. Advantages in production, logistics management and resource integration 6, diabetes diagnosis and care "O+O" new model advantages 7, years of deep cultivation of healthy Internet of things formed comprehensive advantages 8. Advantages of team cohesion with consistent values